HER2 Positive Gastric Cancer Market

Future Market Insights

Key Insight

The HER2 positive gastric cancer market is projected to grow from USD 1.4 billion in 2025 to USD 1.9 billion by 2035, at a CAGR of 3.5%. Targeted Therapy will dominate with a 38.6% market share, while stage iv will lead the stage segment with a 41.2% share.

August 21, 2025

Anurag Sharma

300 Pages

Cite this Report

HER2 Positive Gastric Cancer Market

https://www.futuremarketinsights.com/reports/her2-positive-gastric-cancer-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Novartis
Ono Pharmaceutical Co. Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

HER2 Positive Gastric Cancer Market

Key Players

Similar Industry Reports